MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Prognostic Value of Parkinson’s Disease Subtypes in the LABS-PD Cohort: Functional ability, Quality of life and Mortality

D. Dash, S. Eberly, D. Oakes, D. Grimes, A. Lang, C. Tanner, C. Marras, T. Mestre (Ottawa, Canada)

Meeting: 2024 International Congress

Abstract Number: 443

Keywords: Parkinson’s

Category: Epidemiology

Objective: To assess the prognostic relevance of a data-driven PD subtyping system generated in the Longitudinal and Biomarker Studies in Parkinson’s disease study (LABS-PD) in terms of functional ability, quality of life and mortality

Background: Research on Parkinson’s disease heterogeneity and subtyping may inform prognosis by predicting clinical milestones. Prognostic relevance of clinically meaningful outcomes are desirable characteristics of a PD subtyping solution.  Previously defined PD subtypes’ prognostic value has been generally understudied.

Method: To identify PD subtypes, we conducted cluster analyses in the LABS-PD cohort with 461 PD patients enrolled in the randomized controlled trial CEP-1347 (PRECEPT) within two years of diagnosis, followed for at least five years. We determined the association of each subtype with change in the Schwab & England-Activities of Daily Living (SE-ADL) and Parkinson’s Disease Questionnaire -39(PDQ-39)  in a multiple linear regression model. We evaluated the association of each PD subtype with the hazard of death using a multivariable Cox proportional hazard regression model.

Results: We identified three subtypes: Tremor Predominant (n = 253), Motor complications (n = 183), and  Rapid progression (n = 25). A two-year score change of SE-ADL for the ‘Motor complications’ subtype ( -4.26, 95 CI: -6.60, -1.91) was worse compared to the ‘Tremor Predominant’ subtype (2.22, 95 CI: 0.43.-1.35). Only the ‘Motor complications’ subtype had a significant worsening of PDQ-39 score at two years. The adjusted death rate was higher for the ‘Motor Complications’ subtype compared with the ‘Tremor Predominant subtype (HR (time to death): 0.27, 95 CI:0.14, 0.52, with a significant interaction between age at subtype definition and subtype. In those >65 years of age, cumulative mortality was higher in the ‘Motor Complications’ subtype compared with ‘Tremor Predominant’ subtype.

Conclusion: PD subtypes generated in LABS-PD have some prognostic value for short-term functional ability and long-term survival. Membership to the “Tremor Predominant” subtype at 5 years after PD diagnosis was associated with preserved functional ability and longer survival compared to the “Motor Complications” subtype, particularly for those >65 years. Future work should focus on replicating the results in independent cohorts and validating clinical applicability at individual level.

To cite this abstract in AMA style:

D. Dash, S. Eberly, D. Oakes, D. Grimes, A. Lang, C. Tanner, C. Marras, T. Mestre. Prognostic Value of Parkinson’s Disease Subtypes in the LABS-PD Cohort: Functional ability, Quality of life and Mortality [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/prognostic-value-of-parkinsons-disease-subtypes-in-the-labs-pd-cohort-functional-ability-quality-of-life-and-mortality/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/prognostic-value-of-parkinsons-disease-subtypes-in-the-labs-pd-cohort-functional-ability-quality-of-life-and-mortality/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley